Related Experiment Video
Updated: May 27, 2026
Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
Published on: January 7, 2019
A competitive cell growth assay for the detection of subtle effects of gene transduction on cell proliferation
J J M Eekels1, A O Pasternak, A M Schut
1Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Abstract:
RNA interference (RNAi) is a sequence-specific gene silencing mechanism with therapeutic potential against many human pathogens. To obtain a durable therapeutic effect, stable transduction of target cells with for instance a lentiviral vector that expresses a short hairpin (shRNA) inducer of the RNAi pathway is necessary. Apart from the intended therapeutic effect, this treatment can induce negative effects on cell proliferation via off-target effects. A careful evaluation of the transduced cells is required to develop a safe gene therapy approach. Stably transduced cells are usually selected by expression of the enhanced green fluorescent protein (GFP) marker. In this study we show that the mixed transduction culture, containing both transduced GFP(+) and untransduced GFP(-) cells, can simply be passaged to score the GFP(+)/GFP(-) ratio by longitudinal flow cytometric analysis as a measure of the negative impact of the RNAi treatment on the cellular proliferation rate. We show that this assay is sensitive, easy to use and internally controlled for assessing subtle effects on cell proliferation of lentiviral transduction and transgene expression.
Insights
This study introduces a simple flow cytometry assay to monitor cell proliferation during RNA interference (RNAi) gene therapy. The method tracks the ratio of green fluorescent protein (GFP)-positive to GFP-negative cells to assess treatment safety.
Area of Science:
- Molecular Biology
- Gene Therapy
- Cell Biology
Background:
- RNA interference (RNAi) offers therapeutic potential for human pathogens.
- Stable gene silencing requires lentiviral vector transduction expressing short hairpin RNA (shRNA).
- Lentiviral transduction can cause unintended negative effects on cell proliferation through off-target effects.
Purpose of the Study:
- To develop a sensitive and internally controlled assay for evaluating lentiviral transduction and RNAi effects on cell proliferation.
- To assess the impact of RNAi gene therapy on cellular proliferation rates.
- To ensure the safety of gene therapy approaches by monitoring cell health.
Main Methods:
- Utilizing mixed transduction cultures of green fluorescent protein (GFP)-positive (transduced) and GFP-negative (untransduced) cells.
- Employing longitudinal flow cytometric analysis to measure the GFP(+)/GFP(-) ratio over time.
- Passaging cells to longitudinally track proliferation rates and treatment effects.
Main Results:
- The GFP(+)/GFP(-) ratio accurately reflects the impact of RNAi on cell proliferation.
- The assay is sensitive, easy to use, and internally controlled.
- Subtle effects of lentiviral transduction and transgene expression on cell proliferation can be detected.
Conclusions:
- This flow cytometry-based assay provides a reliable method for assessing the safety of RNAi-based gene therapies.
- The assay facilitates the evaluation of potential negative impacts on cell proliferation.
- It is a valuable tool for the development of safe and effective gene therapy strategies.
More Related Videos
12:35Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Published on: September 3, 2016
12:22A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
Published on: September 22, 2019